HomeBUSINESS
BUSINESS

Adcetris Gets European Panel Backing for CTCL: Takeda
(Nov.16.2017)

Takeda Pharmaceutical said on November 15 that its lymphoma drug Adcetris (brentuximab vedotin) gained the blessing of a key European panel for its label extension for CD30-positive cutaneous T-cell lymphoma (CTCL) ...
(LOG IN FOR FULL STORY)